MX2020009313A - Composiciones y metodos para renovacion de la piel. - Google Patents

Composiciones y metodos para renovacion de la piel.

Info

Publication number
MX2020009313A
MX2020009313A MX2020009313A MX2020009313A MX2020009313A MX 2020009313 A MX2020009313 A MX 2020009313A MX 2020009313 A MX2020009313 A MX 2020009313A MX 2020009313 A MX2020009313 A MX 2020009313A MX 2020009313 A MX2020009313 A MX 2020009313A
Authority
MX
Mexico
Prior art keywords
skin
methods
compositions
skin renewal
modulate
Prior art date
Application number
MX2020009313A
Other languages
English (en)
Inventor
tianan Jiang
Cynthia Latham
Stephen Roman
Randa Nabaty
Christin Powell
Original Assignee
Plexus Worldwide Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plexus Worldwide Llc filed Critical Plexus Worldwide Llc
Publication of MX2020009313A publication Critical patent/MX2020009313A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Diferentes modalidades proporcionan composiciones tópicas y métodos para tratar la piel para modular el microbioma de la piel. La aplicación de diferentes modalidades de la composición tópica puede modular el crecimiento de diferentes bacterias comensales en el microbioma de la piel cuando se aplica a la piel, lo cual puede mejorar la función inmune de la piel y/o reducir el envejecimiento prematuro de la piel.
MX2020009313A 2018-03-08 2019-03-08 Composiciones y metodos para renovacion de la piel. MX2020009313A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862640440P 2018-03-08 2018-03-08
PCT/US2019/021468 WO2019173782A1 (en) 2018-03-08 2019-03-08 Compositions and methods for skin renewal

Publications (1)

Publication Number Publication Date
MX2020009313A true MX2020009313A (es) 2020-11-24

Family

ID=67845825

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020009313A MX2020009313A (es) 2018-03-08 2019-03-08 Composiciones y metodos para renovacion de la piel.

Country Status (6)

Country Link
US (2) US20210069088A1 (es)
AU (1) AU2019232004A1 (es)
CA (1) CA3093384A1 (es)
CO (1) CO2020012513A2 (es)
MX (1) MX2020009313A (es)
WO (1) WO2019173782A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3906013A1 (en) 2019-01-02 2021-11-10 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
EP4034093A1 (en) 2019-12-02 2022-08-03 Sytheon Limited Compositions comprising meroterpenes and linoleic acid derivatives and their use for regulating the endocannabinoid system
WO2021170409A1 (en) * 2020-02-25 2021-09-02 Unilever Ip Holdings B.V. Use of a combination of a saccharide and glycerol for prebiotic benefits
US20210371353A1 (en) * 2020-06-02 2021-12-02 Lanny L. Johnson Fertilizer compositions and plants containing protocatechuic acid, and uses thereof
JP2023542165A (ja) * 2020-09-25 2023-10-05 ディーエスエム アイピー アセッツ ビー．ブイ． エピロビウム・フレイスケリ（ｅｐｉｌｏｂｉｕｍ ｆｌｅｉｓｃｈｅｒｉ）抽出物の新規な利用
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
FI130198B (en) * 2021-03-26 2023-04-17 Lumene Oy The use of Nordic berry ingredients to support a healthy skin microbiome
CN115919734B (zh) * 2022-12-29 2023-07-14 山东福瑞达生物股份有限公司 一种共培养表皮葡萄球菌发酵液及其应用
CN117645968A (zh) * 2023-12-05 2024-03-05 上海应用技术大学 一种益生元促进表皮葡萄球菌ccsm0322生长的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210681B1 (en) * 1999-09-07 2001-04-03 Jlb, Inc. Plant proanthocyanidin extracts
AU2001251610A1 (en) * 2000-04-13 2001-11-07 Ocean Spray Cranberries, Inc. Novel compositions derived from cranberry and grapefruit and therapeutic uses therefor
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
FR2930153B1 (fr) * 2008-04-21 2012-05-04 Oreal Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques
FR2954140A1 (fr) * 2009-12-17 2011-06-24 Oreal Compositions cosmetiques ou dermatologiques a base de bacteriocines et de prebiotiques
JP2015507011A (ja) * 2012-02-14 2015-03-05 ザ プロクター アンド ギャンブルカンパニー 皮膚共生プレバイオティック剤及びそれを含有する組成物の局所使用
WO2013154725A1 (en) * 2012-04-13 2013-10-17 Trustees Of Boston College Prebiotic compositions and methods of use
US9314494B2 (en) * 2012-05-25 2016-04-19 The United States Of America, As Represented By The Secretary Of Agriculture Cranberry xyloglucan oligosaccharide composition
US11160745B2 (en) * 2014-04-18 2021-11-02 Gregory P. Pilant Methods and compositions for topical delivery for skin care
KR20180086510A (ko) * 2015-12-18 2018-07-31 마리 케이 인코포레이티드 국소 화장품 제형
KR20180089552A (ko) * 2015-12-30 2018-08-08 마리 케이 인코포레이티드 국소 조성물
US10219993B2 (en) * 2015-12-31 2019-03-05 L'oreal Systems and methods for improving the appearance of the skin
EP3405166A1 (en) * 2016-01-22 2018-11-28 Edgewell Personal Care Brands, LLC Hydrophobic topical compositions
CA3019127A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Topical composition for reducing pathogen binding

Also Published As

Publication number Publication date
US20210069088A1 (en) 2021-03-11
CO2020012513A2 (es) 2020-10-30
WO2019173782A1 (en) 2019-09-12
US20230060688A1 (en) 2023-03-02
AU2019232004A1 (en) 2020-10-01
CA3093384A1 (en) 2019-09-12

Similar Documents

Publication Publication Date Title
MX2020009313A (es) Composiciones y metodos para renovacion de la piel.
EA202091389A1 (ru) Композиция на основе пробиотиков и её применение
PH12020500240A1 (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
CA3156451A1 (en) ANTIBODIES WITH SPECIFICITY FOR NECTIN-4 AND THEIR USES
WO2020039321A3 (en) Anti-gdf15 antibodies, compositions and methods of use
WO2018229236A3 (en) COMPOSITIONS COMPRISING BACTERIAL STRAINS
WO2019224716A3 (en) Antibodies specific for gucy2c and uses thereof
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
EP4248996A3 (en) Anti-trem2 antibodies and methods of use thereof
SA521422031B1 (ar) مركبات 2 – فورميل – 3 – هيدروكسي فينيلوكسي ميثيل قادرة على تعديل الهيموجلوبين
PH12020552229A1 (en) Il-11ra antibodies
CR20210197A (es) Anticuerpos anti-hla-g, composiciones que comprenden anticuerpos anti-hla-g y métodos de uso de anticuerpos anti-hla-g
MX2020007945A (es) Proteinas f del rsv estabilizadas y usos de las mismas.
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
MX2021011983A (es) Compuestos de neuregulina-4 y metodos de uso.
MX2021008460A (es) Composición probiótica a base de esporas para modulación de propiedades dérmicas y subdérmicas.
MX2020003762A (es) Composiciones cosmeticas y metodo para tratar la piel.
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
MX2021000719A (es) Composicion de microbiota fecal, para su uso en la reduccion de la inflamacion inducida por tratamiento.
MX2023004869A (es) Anticuerpos contra sars-cov-2 y usos de los mismos.
MX2021015156A (es) Anticuerpos anti-pcrv que se unen a pcrv, composiciones que comprenden anticuerpos anti-pcrv, y metodos de uso de estos.
WO2020123816A3 (en) Anellosomes and methods of use
MX2021008834A (es) Metodos de tratamiento del cancer de mama con tucatinib.
WO2019075216A8 (en) Plectin-1 binding antibodies and uses thereof
MX2018007468A (es) Composiciones de colageno 7 y metodos para usar las mismas.